BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11555091)

  • 1. Are serum anticonvulsant levels in people with epilepsy appropriately monitored?
    Thapar A; Richens A; Roland M; Jacoby A; Russell I; Roberts C; Porter E; Wall S
    J Eval Clin Pract; 2001 Aug; 7(3):335-8. PubMed ID: 11555091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of total and free anticonvulsant serum levels in clinical practice.
    Beran RG; Lewis JH; Nolte JL; Westwood AP
    Clin Exp Neurol; 1985; 21():69-77. PubMed ID: 3939613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug interaction between phenytoin and valproic acid in a child with refractory epilepsy: a case report.
    Carvalho IV; Carnevale RC; Visacri MB; Mazzola PG; de Fátima Lopes Ambrósio R; dos Reis MC; de Queiroz RA; Moriel P
    J Pharm Pract; 2014 Apr; 27(2):214-6. PubMed ID: 24381240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of unbound antiepileptic drug blood levels in the management of epilepsy.
    Lenn NJ; Robertson M
    Neurology; 1992 May; 42(5):988-90. PubMed ID: 1579255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of measuring anticonvulsant blood levels in epilepsy.
    Brett E
    Dev Med Child Neurol; 1977 Apr; 19(2):245-51. PubMed ID: 323092
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of sodium valproate and phenytoin as single drug treatment in epilepsy.
    Shakir RA; Johnson RH; Lambie DG; Melville ID; Nanda RN
    Epilepsia; 1981 Feb; 22(1):27-33. PubMed ID: 6781888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of valproate on free plasma phenytoin concentrations.
    Tsanaclis LM; Allen J; Perucca E; Routledge PA; Richens A
    Br J Clin Pharmacol; 1984 Jul; 18(1):17-20. PubMed ID: 6430316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of anticonvulsants on memory function in epileptic patients: preliminary findings.
    Butlin AT; Wolfendale L; Danta G
    Clin Exp Neurol; 1981; 17():79-84. PubMed ID: 6809375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spotlight on the continual applicability of routine plasma monitoring antiepileptic drugs in the treatment of epilepsy.
    El Desoky E; Kandil MR; Afifi AH; Mostafa OA
    Pharmacol Res; 1999 Apr; 39(4):269-74. PubMed ID: 10208756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five years of anticonvulsant monitoring on site at the epilepsy clinic.
    McKee PJ; Larkin JG; Brodie AF; Percy-Robb IW; Brodie MJ
    Ther Drug Monit; 1993 Apr; 15(2):83-90. PubMed ID: 8503143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum concentrations and enzyme induction in epileptic children treated with phenytoin and valproate.
    de Wolff FA; Peters AC; van Kempen GM
    Neuropediatrics; 1982 Feb; 13(1):10-3. PubMed ID: 6123089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiepileptic drug therapy and its management in sudden unexpected death in epilepsy: a case-control study.
    Nilsson L; Bergman U; Diwan V; Farahmand BY; Persson PG; Tomson T
    Epilepsia; 2001 May; 42(5):667-73. PubMed ID: 11380576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. The Italian TDM Study Group in Epilepsy.
    Jannuzzi G; Cian P; Fattore C; Gatti G; Bartoli A; Monaco F; Perucca E
    Epilepsia; 2000 Feb; 41(2):222-30. PubMed ID: 10691121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate.
    Forsythe I; Butler R; Berg I; McGuire R
    Dev Med Child Neurol; 1991 Jun; 33(6):524-34. PubMed ID: 1864478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenytoin-valproate interaction: importance of saliva monitoring in epilepsy.
    Knott C; Hamshaw-Thomas A; Reynolds F
    Br Med J (Clin Res Ed); 1982 Jan; 284(6308):13-6. PubMed ID: 6797618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma uric acid in patients receiving anticonvulsant monotherapy.
    Ring HA; Heller AJ; Marshall WJ; Johnson AL; Reynolds EH
    Epilepsy Res; 1991 Apr; 8(3):241-4. PubMed ID: 1868823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of single doses of sodium valproate on serum phenytoin levels and protein binding in epileptic patients.
    Monks A; Richens A
    Clin Pharmacol Ther; 1980 Jan; 27(1):89-95. PubMed ID: 6985856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma arginine vasopressin concentrations in epileptics under monotherapy.
    Krause KH; Rascher W; Berlit P
    J Neurol; 1983; 230(3):193-6. PubMed ID: 6197514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of sodium valproate and phenytoin as single drug treatment in generalised and partial epilepsy.
    Rastogi P; Mehrotra TN; Agarwala RK; Singh VS
    J Assoc Physicians India; 1991 Aug; 39(8):606-8. PubMed ID: 1814875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.